It's time to lace up the sneakers for March Madness! Back for a second year, you can come to work comfortably in your sneakers while fighting back against cancer at the same time! On Tuesday, March 17, associates will have the opportunity to wear sneakers, jeans and your favorite team apparel to work!
$5 Donation - Wear your Sneakers to work with your normal dress apparel.
$10 Donation - Wear your Sneakers with Jeans!
$20 Donation - Wear your Sneakers with Jeans & your Favorite Team Apparel!
Donations of $50 or More!! - Wear your Sneakers ALL WEEK! (Plus Above)
SWEETEST SNEAKER CONTEST!!
Think your kicks are the best? With your donation of $5 or more you can enter into the Sweetest Sneaker Contest! A select group of Executives will be choosing the Sweetest Sneakers and the winner will get a 'sweet' prize!
To enter, send a picture of you wearing your Sneakers (from mid-calf down) to Lindsey.Puetz@kohler.com with the subject line "Sweetest Sneakers Contest Entry" by 5pm on Tuesday, March 17th.
100% of the profits benefit the American Cancer Society's Coaches vs. Cancer Bo Ryan - Jay Holliday Families Fund.
The Coaches vs. Cancer Bo Ryan - Jay Holliday Families Fund was established in 2018 in honor of Coach Ryan's longtime friend and former college roommate, Jay Holliday, who lost his battle with pancreatic cancer. All dollars raised for the Bo Ryan - Jay Holliday Families Fund are restricted to American Cancer Society-funded research at the Carbone Cancer Center in Madison, WI.
Currently, two researchers at Carbone have been selected to receive funding thanks to this Fund:
· Randall J. Kimple, MD, PhD, Therapy Induced Autophagy in Head and Neck Cancer Patients: Head and neck cancer is typically associated with advanced stage diagnosis, high recurrence rates, and poor long-term outcomes – survival rates for this cancer have not improved over the past decade. Dr. Kimple’s research will use tissue samples to study the resistance of head and neck cancer cells to a specific chemotherapy drug, as well as analyze whether treatment for head and neck cancers with that drug should include another drug(s) to help block the cancer’s resistance to this type of chemotherapy.
· Pamela K. Kreeger, PhD, Inhibition of Metastasis in Ovarian Cancer: Ovarian cancer is often diagnosed at a late stage and after the disease has spread (metastasized) to other abdominal organs or tissue. Dr. Kreeger’s research will study the efficacy of an FDA-approved drug in slowing or stopping metastases by blocking the production and function of a protein known to enable ovarian cancer cells easily attaching to other parts of the abdomen. These results will then allow Dr. Kreeger to identify any biomarkers that could help further identify those patients who would benefit most from this approach.
Thanks for joining in the March Madness and fighting back against cancer!